Barriers to translational research in Sjogren's syndrome with childhood onset: challenges of recognising and diagnosing an orphan rheumatic disease
Barriers to translational research in Sjogren's syndrome with childhood onset: challenges of recognising and diagnosing an orphan rheumatic disease
复制标题
DOI:
10.1016/s2665-9913(20)30393-3
复制
发表时间:
2021-01-28
影响因子:
25.4
通讯作者:
Price, Elizabeth J.
中科院分区:
文献类型:
--
作者:
Ciurtin, Coziana;Cho, Youna;Price, Elizabeth J.
Sj?gren?s syndrome is an autoimmune rheumatic disease characterised by chronic lymphocytic infiltration of the exocrine glands, leading to dryness (eg, of the mouth, eyes, respiratory tract, and vagina) that is considered the main symptom of the disease.1 The true prevalence of Sj?gren?s syndrome is unclear because of the various classification criteria and study methods used, but it ranges from 2?48 to 20?10 patients per 10 000 inhabitants, according to one meta-analysis.2 The variability of Sj?gren?s syndrome mani festations in different patients, particularly related to their disease onset (within paedi atric versus adult age) is reflected in the difficulty of developing universally applicable classification criteria. Sj?gren?s syndrome is better characterised in adults than it is in children. The estimated prevalence in the adult general population is 0?09?1?60%.3,4 If the disease onset is before 18 years of age, patients are described as having juvenile Sj?gren?s syndrome or childhood Sj?gren?s syndrome. There are almost no epidemiologicalSj?gren?s syndrome was considered for many years a disease of adulthood, characterised by immune infiltration of exocrine glands, leading to dryness (eg, dry mouth and eyes), which is a cardinal symptom. As of the last 20 years, it became apparent that although the disease is very rare in children, its clinical presentation differs from that of adults, posing substantial challenges to the recognition, diagnosis, and classification of patients with childhood-onset Sj?gren?s syndrome. This Viewpoint explores comparative classification criteria for children (not validated) and adults with Sj?gren?s syndrome, as well as differences in the clinical presentation of childhood-onset versus adult-onset Sj?gren?s syndrome, offering ideas about how we can improve the diagnosis of Sj?gren?s syndrome in children. A review of the role of medical history and clinical assessment, serology, glandular function assessment, and imaging, as well as salivary and lachrymal gland biopsy in the diagnosis of children with Sj?gren?s syndrome is included. Additionally, we provide suggestions about further research and registry data collection that is required to address the unmet needs of these patients.